Skip to main navigation Skip to search Skip to main content

PARAGLIDE-HF: A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP safety, and tolerability in HFpEF

Project: Research

Project Details

StatusFinished
Effective start/end date03/14/22 → 12/31/25

Funding

  • Novartis Pharmaceuticals Corporation: $31,320.00